Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bronchopulmonary Dysplasia: early-phase trial registry
13 of 30 indexed Bronchopulmonary Dysplasia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #519 of 28,707 conditions by registered trial count.
30 US clinical trials · 13 currently recruiting · #519 of 28,707 conditions by registered trial count
Bronchopulmonary Dysplasia: 30 US clinical trials tracked, 13 recruiting.
Bronchopulmonary Dysplasia is the subject of 30 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is University of Alabama at Birmingham, running 3 of these trials.
Enrollment posture brief
Registry condition bronchopulmonary-dysplasia
OPEN 13 | RECR 43% | LATE 4 | EARLY 9 | RANK #519 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Chronic Lymphocytic Leukemia (CLL) (43% recruiting · 30 trials)
Bronchopulmonary Dysplasia lists 13 open slots (43% of 30 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Bronchopulmonary Dysplasia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Bronchopulmonary Dysplasia is recruiting above its size-band peers.
13 of 30 indexed trials (43.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Bronchopulmonary Dysplasia trials is spread across many organizations.
University of Alabama at Birmingham accounts for 3 of 30 trials (10%). 23 distinct sponsors appear on at least one study for this condition label.
-
Typical Bronchopulmonary Dysplasia enrolment sits around 130 participants.
Median target enrolment is 130 among the 30 trials that report a genuine target (sentinel values excluded). 12 of those (40%) plan for fewer than 100 participants.
-
Bronchopulmonary Dysplasia research is mostly interventional.
23 interventional and 7 observational studies make up this index (76.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
30 total, page 1 of 1
Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)
University of Texas Southwestern Medical Center
NCT05849077
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
University of Pennsylvania
NCT05446272
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
OHB Neonatology
NCT03253263
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
Shirley Ryan AbilityLab
NCT05568264
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
University of Florida
NCT06000761
MRI in BPD Subjects
Children's Hospital Medical Center, Cincinnati
NCT03657693
Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
Children's Hospital of Philadelphia
NCT06475976
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
University of Colorado, Denver
NCT03797183
Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
Winston Manimtim
NCT04270045
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
Children's Hospital of Philadelphia
NCT06534359
Inhaled Ciclesonide Study in Preterm Infants
Venkatesh Sampath
NCT06589245
Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study
Le Bonheur Children's Hospital
NCT06821776
Ventilator Pressure and Optimization of Compliance and Hemodynamics
University of Alabama at Birmingham
NCT06512935
Pulmonary Function Using Non-invasive Forced Oscillometry
University of Alabama at Birmingham
NCT03346343
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
Nationwide Children's Hospital
NCT03782610
A Cohort Study of the Intestinal Microbiota of Premature Infants
University of California, Davis
NCT03717584
Hydrocortisone for BPD
NICHD Neonatal Research Network
NCT01353313
Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia
Roberta Ballard
NCT01022580
Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
Mallinckrodt
NCT00931632
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
University of Rochester
NCT01607216
Trial II of Lung Protection With Azithromycin in the Preterm Infant
Hubert Ballard
NCT00319956
Safety of Sildenafil in Premature Infants
University of North Carolina, Chapel Hill
NCT03142568
Delivery Room CPAP in Extremely Low Birth Weight Infants
NICHD Neonatal Research Network
NCT01223274
Vitamin D Supplementation for Extremely Preterm Infants
University of Alabama at Birmingham
NCT01600430
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Tufts Medical Center
NCT01941745
Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide
Roberta Ballard
NCT00569530
Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)
University of North Carolina, Chapel Hill
NCT02527798
Relationship Between EIT and Respiratory Status in Very Preterm Infants
Lawrence Rhein
NCT06609135
Work of Breathing During Non-invasive Ventilation in Premature Neonates
Arkansas Children's Hospital Research Institute
NCT02788110
Montelukast in Very Low Birthweight Infants
Children's Hospital Medical Center, Cincinnati
NCT00492102
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 6 |
| Phase 3 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Bronchopulmonary Dysplasia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Bronchopulmonary Dysplasia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Bronchopulmonary Dysplasia page
30 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 13 Bronchopulmonary Dysplasia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Alabama at Birmingham sponsors the most Bronchopulmonary Dysplasia trials on record, review their full trial history before evaluating a specific study. See University of Alabama at Birmingham's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bronchopulmonary Dysplasia condition card totals 30 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.